PHARMACEUTICAL COMPOSITION COMPRISING NO OR AT LEAST A NO DONOR COMPOUND OR ANOTHER COMPOUND CAPABLE OF RELEASING OR INDUCING NO FORMATION IN CELLS

摘要

The invention concerns the use of NO, a NO donor compound or a compound capable or releasing, stimulating or inducing NO formation in cells to prepare a medicine for treating or preventing a disease resulting from deficiency of an adult gene in a person for the re-expression of said homologous foetal gene. The invention particularly concerns the treatment of Duchenne or Becker muscular dystrophy, or thalassemia or sickle cell disease.